Jun Qian
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hematology 156
- Acute Myeloid Leukemia Research 142
- Chronic Myeloid Leukemia Treatments 12
- Hematopoietic Stem Cell Transplantation 5
-
- MicroRNA in disease regulation 19
- Co-authors
- Jiang Lin (141 shared papers)Ji‐chun Ma (94 shared papers)Zhaoqun Deng (66 shared papers)Xiang‐mei Wen (68 shared papers)Jing‐dong Zhou (76 shared papers)Dong‐ming Yao (57 shared papers)Jing Chun Yang (42 shared papers)Zi‐jun Xu (54 shared papers)
- Journals
- Leukemia Research (11 papers)Journal of Cellular Physiology (7 papers)Oncotarget (7 papers)Cancer Medicine (6 papers)Clinical Biochemistry (6 papers)
- Partner nations
- ChinaCanadaUnited Kingdom
In The Last Decade
Jun Qian
178 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 75
- Hematology 1.6k
- Cancer Research 777
- Molecular Biology 707
- Oncology 220
- Genetics 80
Countries citing papers authored by Jun Qian
This map shows the geographic impact of Jun Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Qian more than expected).
Fields of papers citing papers by Jun Qian
This network shows the impact of papers produced by Jun Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Qian. The network helps show where Jun Qian may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 169 | |
| 2 | 2013 | 128 | |
| 3 | 2012 | 115 | |
| 4 | 2011 | 107 | |
| 5 | 2011 | 91 | |
| 6 | 2018 | 86 | |
| 7 | 2019 | 72 | |
| 8 | 2012 | 71 | |
| 9 | 2019 | 63 | |
| 10 | 2013 | 58 | |
| 11 | 2017 | 56 | |
| 12 | 2013 | 53 | |
| 13 | 2019 | 51 | |
| 14 | 2013 | 47 | |
| 15 | 2012 | 46 | |
| 16 | 2017 | 43 | |
| 17 | 2024 | 43 | |
| 18 | Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD. | 2014 | 42 |
| 19 | 2014 | 41 | |
| 20 | 2008 | 39 |
About Jun Qian
Jun Qian is a scholar working on Hematology, Cancer Research, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 183 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (142 papers), Epigenetics and DNA Methylation (19 papers), MicroRNA in disease regulation (19 papers), Chronic Myeloid Leukemia Treatments (12 papers), Hematopoietic Stem Cell Transplantation (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Hematology (1.6k citations), Cancer Research (777 citations), Molecular Biology (707 citations), Oncology (220 citations) and Genetics (80 citations). Jun Qian has collaborated with scholars based in China, Canada and United Kingdom. Frequent co-authors include Jiang Lin, Ji‐chun Ma, Zhaoqun Deng, Xiang‐mei Wen, Jing‐dong Zhou, Dong‐ming Yao, Jing Chun Yang, Zi‐jun Xu, Ting‐juan Zhang and Wei Qian. Their work appears in journals such as Leukemia Research, Journal of Cellular Physiology, Oncotarget, Cancer Medicine and Clinical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.